Where the HI-Virus sleeps in the brain

An infection with the human immunodeficiency virus (HIV) is in 99,9% of cases still an incurable disease. This is because the virus "sleeps" for a long time in the genome of infected cells, making it invisible and inaccessible to the immune system and antiviral drugs. The pathways that HIV-1 takes to remain hidden in the host cell genome have been studied primarily in blood CD4+ T cells -- the main target cells of the virus. However, HIV-1 is capable of infecting other immune cells in different organs, where it establishes stable reservoirs. One such viral sanctuary is the brain, where the virus infects mostly microglia immune cells, often causing neuroinflammation and symptoms of HIV-1 associated neurocognitive disorder (HAND).

Questions related to HIV-1 infection and replication in the brain have been very difficult to resolve because studies in patients are limited in their ability to monitor the virus in the brain. An international team led by Dr Marina Lusic from Heidelberg University Hospital and the DZIF now succeeded in developing HIV-1-infection models in human microglia cell cultures. Establishment of the models allowed for the first time to investigate the insertion of the HIV-1 genome in that of microglia cells. Genomic insertion results in the silencing of the viral genome, leading to the so-called "sleeping virus" phenotype.

The researchers, who recently published their findings in the scientific journal Cell Reports, used the microglia cell models to determine HIV-1 integration sites and associate them with structural and regulatory elements of the chromatin.

"Modelling HIV-1-infections of the brain immune cells using the microglia cell cultures, we discovered a stronger correlation between a cellular chromatin factor and the sleeping virus phenotype," says the paper's first author Mona Rheinberger. "This protein, called CTCF, is one of the most important architectural proteins of the cellular genome, involved in chromatin folding and packaging inside the cells. Our findings indicate that CTCF is shaping the HIV-1 genomic insertion profiles in microglia, thus contributing to the latent infection state."

"These studies in cell culture models are extremely important to understand how the virus can be targeted in different parts of the body, where it can remain hidden or cause neurological disorders even under current therapeutic regimens," Dr Lusic concludes.